Acupuncture shows a tendency towards benefit along with a lack of adverse effects in patients with chemotherapy-induced peripheral neuropathy (CIPN), conclude a team of Brazilian researchers. In a pilot study, 33 adult patients with cancer and CIPN were randomised to either an acupuncture (ten 30 minute sessions, twice per week for five weeks) group or a control group. Both groups received guidance on medical management and self-care for neuropathy. Significant differences were found for physical and functional domains of cancer-related quality of life in favour of acupuncture. Improvements in neuropathy symptom scores were seen in the acupuncture group, while in the control group no such differences in scores were observed.

Acupuncture for chemotherapy-induced peripheral neuropathy: a randomized controlled pilot study. BMJ Support Palliat Care. 2022 Mar;12(1):64-72.